\-\ Texto\\:\\ \ \(0\)\
\-\ mri\\:\ \(0\)\
\-\ t1\\ images\\ show\\ marrow\\ signal\\ lower\\ than\\ muscle\\ or\\ disk\ \(0\)\
\-\ t2\\/stir\\ images\\ show\\ signal\\ higher\\ than\\ fat\\/muscle\ \(0\)\
\-\ bone\\ scan\ \(157\)\
\-\ early\\ phase\\ bone\\ scan\\ images\\ show\\ increased\\ radiotracer\\ uptake\\ in\\ the\\ long\\ bones\\,\\ particularly\\ in\\ the\\ metadiaphysis\ \(0\)\
\-\ leukemia\ \(70\)\
\-\ diffuse\\ abnormal\\ marrow\\ on\\ mri\ \(0\)\
\-\ \\â\\€\\¢\\ marrow\\ proliferative\ \(0\)\
\-\ \\Â\\»\\ benign\\ \\(myelodysplatic\\ syndrome\\,\\ myelofibrosis\\ polycythemia\\,\\ red\\ marrow\\)\ \(0\)\
\-\ \\Â\\»\\ malignant\\ \\(leukemia\\,\\ multiple\\ myeloma\\,\\ waldenstroms\\ macroglobulinemia\\,\\ amyloid\\)\ \(0\)\
\-\ \\â\\€\\¢\\ marrow\\ replacement\\ \\(osteomyelitis\\,\\ primary\\ bone\\ tumors\\,\\ mets\\,\\ lymphoma\\)\ \(0\)\
\-\ early\\ uptake\\ on\\ pool\\ phase\\ of\\ bone\\ scan\ \(0\)\
\-\ \\â\\€\\¢\\ leukemia\ \(2\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ 5\\ year\\ old\\ male\\ with\\ bone\\ pain\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ marrow\\:\\ 0\\.44204826773872025\ \(0\)\
\-\ leukemia\\:\\ 0\\.2915255027598414\ \(0\)\
\-\ bone\\:\\ 0\\.29023686356336825\ \(0\)\
\-\ show\\:\\ 0\\.20260833722302773\ \(0\)\
\-\ scan\\:\\ 0\\.18935242594977883\ \(0\)\
\-\ phase\\:\\ 0\\.18206738057875704\ \(0\)\
\-\ myelodysplatic\\:\\ 0\\.17013395011663815\ \(0\)\
\-\ waldenstroms\\:\\ 0\\.17013395011663815\ \(0\)\
\-\ uptake\\:\\ 0\\.16360877929457682\ \(0\)\
\-\ macroglobulinemia\\:\\ 0\\.1625720721305094\ \(0\)\
\-\ early\\:\\ 0\\.15337234759875185\ \(0\)\
\-\ polycythemia\\:\\ 0\\.15304523255328967\ \(0\)\
\-\ muscle\\:\\ 0\\.15108181978800628\ \(0\)\
\-\ images\\:\\ 0\\.14763145537133587\ \(0\)\
\-\ myelofibrosis\\:\\ 0\\.14427971851441992\ \(0\)\
\-\ proliferative\\:\\ 0\\.13384294794438584\ \(0\)\
\-\ metadiaphysis\\:\\ 0\\.12915596254216238\ \(0\)\
\-\ signal\\:\\ 0\\.12061409670926534\ \(0\)\
\-\ than\\:\\ 0\\.12061409670926534\ \(0\)\
\-\ amyloid\\:\\ 0\\.12026138303414584\ \(0\)\
\-\ pool\\:\\ 0\\.11165734087719748\ \(0\)\
\-\ myeloma\\:\\ 0\\.11047906157324265\ \(0\)\
\-\ mets\\:\\ 0\\.10937082156409554\ \(0\)\
\-\ mri\\:\\ 0\\.10921799321313358\ \(0\)\
\-\ disk\\:\\ 0\\.10464402849284338\ \(0\)\
\-\ particularly\\:\\ 0\\.10042683835603884\ \(0\)\
\-\ red\\:\\ 0\\.10020612707171603\ \(0\)\
\-\ higher\\:\\ 0\\.09662389929867264\ \(0\)\
\-\ replacement\\:\\ 0\\.09556796338810442\ \(0\)\
\-\ radiotracer\\:\\ 0\\.09286496036991009\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.09171691269173428\ \(0\)\
\-\ bones\\:\\ 0\\.0856014869236016\ \(0\)\
\-\ tumors\\:\\ 0\\.07824123128885047\ \(0\)\
\-\ malignant\\:\\ 0\\.07583554297054276\ \(0\)\
\-\ benign\\:\\ 0\\.07307981939184324\ \(0\)\
\-\ long\\:\\ 0\\.07054469650214064\ \(0\)\
\-\ diffuse\\:\\ 0\\.06671702370776521\ \(0\)\
\-\ primary\\:\\ 0\\.0654157499946345\ \(0\)\
\-\ on\\:\\ 0\\.06426063595636351\ \(0\)\
\-\ syndrome\\:\\ 0\\.06413583618378653\ \(0\)\
\-\ abnormal\\:\\ 0\\.0639151248994637\ \(0\)\
\-\ lymphoma\\:\\ 0\\.06335929245947645\ \(0\)\
\-\ metastatic\\:\\ 0\\.058347253652578555\ \(0\)\
\-\ increased\\:\\ 0\\.0575283466271603\ \(0\)\
\-\ lower\\:\\ 0\\.05436322668782669\ \(0\)\
\-\ in\\:\\ 0\\.05293063630490201\ \(0\)\
\-\ multiple\\:\\ 0\\.05203557824989867\ \(0\)\
\-\ male\\:\\ 0\\.04736702159014238\ \(0\)\
\-\ disease\\:\\ 0\\.044656952068156626\ \(0\)\
\-\ the\\:\\ 0\\.042455617871453244\ \(0\)\
\-\ pain\\:\\ 0\\.03806873103043889\ \(0\)\
\-\ or\\:\\ 0\\.037009702776667305\ \(0\)\
\-\ year\\:\\ 0\\.032785988895634915\ \(0\)\
\-\ old\\:\\ 0\\.03148589849151282\ \(0\)\
\-\ with\\:\\ 0\\.0208316568835041\ \(0\)\
\-\ of\\:\\ 0\\.020819217406064922\ \(0\)\
